Chou TC - Search Results

1

Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors.

Rigas JR, Kris MG, Miller VA, Pisters KM, Heelan RT, Grant SC, Fennelly DW, Chou TC, Sirotnak FM. Rigas JR, et al. Among authors: chou tc. Ann Oncol. 1999 May;10(5):601-3. doi: 10.1023/a:1026404812699. Ann Oncol. 1999. PMID: 10416013 Free article. Clinical Trial.

2

Quantitation of the synergistic interaction of edatrexate and cisplatin in vitro.

Chou TC, Tan QH, Sirotnak FM. Chou TC, et al. Cancer Chemother Pharmacol. 1993;31(4):259-64. doi: 10.1007/BF00685668. Cancer Chemother Pharmacol. 1993. PMID: 8422687

3

Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.

Chou TC, Otter GM, Sirotnak FM. Chou TC, et al. Cancer Chemother Pharmacol. 1996;37(3):222-8. doi: 10.1007/BF00688320. Cancer Chemother Pharmacol. 1996. PMID: 8529281

4

Chemical synthesis and biological activities of 5-deazaaminopterin analogues bearing substituent(s) at the 5- and/or 7-position(s).

Su TL, Huang JT, Chou TC, Otter GM, Sirotnak FM, Watanabe KA. Su TL, et al. Among authors: chou tc. J Med Chem. 1988 Jun;31(6):1209-15. doi: 10.1021/jm00401a023. J Med Chem. 1988. PMID: 3373490

5

9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships.

Su TL, Chou TC, Kim JY, Huang JT, Ciszewska G, Ren WY, Otter GM, Sirotnak FM, Watanabe KA. Su TL, et al. Among authors: chou tc. J Med Chem. 1995 Aug 18;38(17):3226-35. doi: 10.1021/jm00017a006. J Med Chem. 1995. PMID: 7650675

6

Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability.

Kong XB, Rubin L, Chen LI, Ciszewska G, Watanabe KA, Tong WP, Sirotnak FM, Chou TC. Kong XB, et al. Among authors: chou tc. Mol Pharmacol. 1992 Feb;41(2):237-44. Mol Pharmacol. 1992. PMID: 1311406

7

Paclitaxel in germ cell cancer.

Motzer RJ, Chou TC, Schwartz L, Bosl GJ, Bajorin DF, Hutter H. Motzer RJ, et al. Among authors: chou tc. Semin Oncol. 1995 Jun;22(3 Suppl 6):12-5. Semin Oncol. 1995. PMID: 7597428 Review.

8

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

Conti JA, Kemeny NE, Saltz LB, Huang Y, Tong WP, Chou TC, Sun M, Pulliam S, Gonzalez C. Conti JA, et al. Among authors: chou tc. J Clin Oncol. 1996 Mar;14(3):709-15. doi: 10.1200/JCO.1996.14.3.709. J Clin Oncol. 1996. PMID: 8622015

9

Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo.

Takahashi N, Li W, Banerjee D, Guan Y, Wada-Takahashi Y, Brennan MF, Chou TC, Scotto KW, Bertino JR. Takahashi N, et al. Among authors: chou tc. Cancer Res. 2002 Dec 1;62(23):6909-15. Cancer Res. 2002. PMID: 12460906

10

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

Lin SF, Gao SP, Price DL, Li S, Chou TC, Singh P, Huang YY, Fong Y, Wong RJ. Lin SF, et al. Among authors: chou tc. Clin Cancer Res. 2008 Mar 1;14(5):1519-28. doi: 10.1158/1078-0432.CCR-07-4628. Clin Cancer Res. 2008. PMID: 18316577 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters